“I didn’t want to meet you.” Dispelling myths about palliative careFebruary 2, 2022Follicular Lymphoma
‘Outstanding data’: Mosunetuzumab in r/r follicular lymphomaDecember 11, 2021B Cell LymphomaFollicular Lymphoma
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021B Cell LymphomaMantle Cell LymphomaDLBCLCLLFollicular Lymphoma
New inhibitor shows promise in previously failed B-cell malignanciesMarch 12, 2021CLLMantle Cell LymphomaFollicular Lymphoma
Novel ddPCR assay precisely measures CAR T-cells after infusionFebruary 22, 2021DLBCLFollicular LymphomaB Cell Lymphoma
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020DLBCLFollicular LymphomaCLLMantle Cell LymphomaB Cell Lymphoma
FDA gives thumbs up to tazemetostat for follicular lymphomaJune 19, 2020B Cell LymphomaFollicular Lymphoma
Lymphocyte, monocyte data can predict treatment response in follicular lymphomaApril 13, 2020Follicular Lymphoma
Follicular lymphoma treatment can benefit patients 80 years and olderMarch 17, 2020Follicular Lymphoma
REGN1979 shows good activity in pretreated aggressive B-NHLJanuary 15, 2020B Cell LymphomaFollicular LymphomaDLBCL
Survival data reported from largest CAR T trial in B-cell lymphomaDecember 20, 2019B Cell LymphomaDLBCLFollicular Lymphoma
